We are live on ! Find out more
ADVM

Adverum Biotechnologies
ADVM

Delisted

ADVM was delisted on the 8th of December, 2025.

Back to rankings

84 hedge funds and large institutions have $719M invested in Adverum Biotechnologies in 2014 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 29 increasing their positions, 14 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

386% more first-time investments, than exits

New positions opened: 34 | Existing positions closed: 7

107% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 14

100% more funds holding in top 10

Funds holding in top 10: 2 → 4 (+2)

72% more capital invested

Capital invested by funds: $419M → $719M (+$300M)

45% more funds holding

Funds holding: 58 → 84 (+26)

Holders
84
Holders Change
+26
Holders Change %
+44.83%
% of All Funds
2.24%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.11%
New
34
Increased
29
Reduced
14
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BFA
BlackRock Fund Advisors
California
+$11M
2
JP Morgan Chase
JP Morgan Chase
New York
+$10.7M
3
FCM
Frontier Capital Management
Massachusetts
+$4.74M
4
Millennium Management
Millennium Management
New York
+$4.4M
5
SM
Sabby Management
Florida
+$3.58M

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$16.7M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$3.15M
3
Marshall Wace
Marshall Wace
United Kingdom
-$1.55M
4
PRCM
Pine River Capital Management
Minnesota
-$998K
5
UBS AM
UBS AM
Illinois
-$985K
Name Holding Trade Value Shares
Change 		Change in
Stake
CCM
26
Cadian Capital Management
New York
$3.24M +$2.31M +6,000 New
BA
27
BlackRock Advisors
Delaware
$2.91M +$12.7K +33 +0.6%
RI
28
RTW Investments
New York
$2.7M +$1.93M +5,000 New
Citadel Advisors
29
Citadel Advisors
Florida
$2.59M +$66.3K +172 +4%
DCM
30
Driehaus Capital Management
Illinois
$2.52M +$484K +1,256 +37%
Geode Capital Management
31
Geode Capital Management
Massachusetts
$2.42M +$416K +1,078 +32%
Axa
32
Axa
France
$2.35M +$1.68M +4,352 New
Primecap Management
33
Primecap Management
California
$2.05M -$305K -790 -17%
Fidelity International
34
Fidelity International
Bermuda
$1.9M +$1.35M +3,515 New
Bank of New York Mellon
35
Bank of New York Mellon
New York
$1.82M +$431K +1,119 +50%
EAM
36
Eventide Asset Management
Massachusetts
$1.75M +$478K +1,240 +62%
Principal Financial Group
37
Principal Financial Group
Iowa
$1.45M +$1.04M +2,690 New
GOCM
38
Green Owl Capital Management
New York
$1.4M +$1M +2,600 New
PRCM
39
Pine River Capital Management
Minnesota
$1.4M -$998K -2,590 -50%
RFC
40
Russell Frank Company
Washington
$1.36M +$971K +2,518 New
EI
41
EAM Investors
California
$1.29M +$923K +2,394 New
BIM
42
BlackRock Investment Management
Delaware
$1.27M +$23.9K +62 +3%
TCIM
43
TIAA CREF Investment Management
New York
$1.24M +$87.5K +227 +11%
CS
44
Credit Suisse
Switzerland
$1.09M +$781K +2,026 New
PAM
45
Panagora Asset Management
Massachusetts
$1.02M -$217K -563 -23%
ProShare Advisors
46
ProShare Advisors
Maryland
$883K +$631K +1,636 New
Morgan Stanley
47
Morgan Stanley
New York
$781K +$214K +555 +62%
Deutsche Bank
48
Deutsche Bank
Germany
$772K +$185K +480 +50%
California State Teachers Retirement System (CalSTRS)
49
California State Teachers Retirement System (CalSTRS)
California
$689K +$1.93K +5 +0.4%
Bank of Montreal
50
Bank of Montreal
Ontario, Canada
$565K +$104K +270 +35%
1
2
3 4

ADVM Hedge Fund Activity: Q4 2014 in Review

84 of the 3,751 institutional investors tracked by Wall St. Rank reported a position in Adverum Biotechnologies (ADVM) for Q4 2014, worth a combined $719M — up 72% from $419M a quarter earlier.

Buyers outnumbered sellers: 34 funds opened new ADVM positions and 7 closed out — a net gain of 27 holders — while 29 added to existing stakes and 14 trimmed.

The largest buyer was BlackRock Fund Advisors, adding an estimated $11M. The largest seller was Deerfield Management, cutting an estimated $16.7M.

  • 84 institutional investors held Adverum Biotechnologies (ADVM) as of Q4 2014, up from 58 in Q3 2014.
  • Funds reported $719M of Adverum Biotechnologies stock for Q4 2014, up 72% quarter-over-quarter.
  • 34 funds opened new Adverum Biotechnologies positions in Q4 2014 and 7 closed out, a net change of +27 holders.
  • The largest Adverum Biotechnologies buyer in Q4 2014 was BlackRock Fund Advisors, an estimated $11M added.
  • The largest Adverum Biotechnologies seller in Q4 2014 was Deerfield Management, an estimated $16.7M sold.

Based on aggregated 13F filings for Q4 2014.